The Diagnostic Accuracy of <sup>18</sup>F-FDG PET and <sup>18</sup>F-FES PET for Staging Grade 1–2 Estrogen Receptor–Positive Breast Cancer
Jelijn J. Knip, Ramsha Iqbal, Emma C Bonjer, Lemonitsa H. Mammatas, Annette A. van Zweeden, Paola Perin, Jaap J.M. Teunissen, Gwen M. P. Diepenhorst, Laura J Schijf, Sandra D. Bakker, Noortje Schoenmakers, Susanne van der Velde, Ellis Barbé, Katya M. Duvivier, Inge R. Konings, Gerben J.C. Zwezerijnen, Albert D. Windhorst, Ronald Boellaard, Daniela E. Oprea‐Lager, C. Willemien Menke‐van der Houven van Oordt
Abstract
In this pilot study, there was no statistical difference in diagnostic accuracy of fluorine 18 ( 18 F) FES PET and 18 F-FDG PET in staging patients with grade 1 or 2, estrogen receptor–positive breast cancer ( P = .18).
Topics & Concepts
MedicineBreast cancerNuclear medicineEstrogen receptorPositron emission tomographyCancerEstrogenInternal medicineMedical Imaging Techniques and ApplicationsBreast Cancer Treatment StudiesRadiomics and Machine Learning in Medical Imaging